VERACYTE, INC. (VCYT)
Services-Medical Laboratories · Healthcare · $4.1B
Intrinsic Value (Consensus)
$13.92
Current Price
$50.92
Margin of Safety
-72.7%
72.7% Above Intrinsic Value
Value: $14
Price: $51
Valuation Model Estimates
Current Price: $50.92
DCF (Discounted Cash Flow)
$74.42
Graham Number
$17.40
Earnings Power Value
$7.96
Relative Value (P/E)
$16.40
Dividend Discount Model
Not applicable
—
Consensus Value
$13.92
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
58
Profitability
15/25
Strength
17/25
Valuation
7/25
Growth
19/25
Financial Health Signals
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $0.82
- EPS (Forward)
- $0.98
- Book Value
- $16.41
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 5.1%
- Debt/Equity
- —
- Revenue Growth
- 16.0%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance